The COVID-19 pandemic caused by the SARS-CoV-2, a ribonucleic acid (RNA) virus that
emerged less than two years ago but has caused nearly 6.1 million deaths to date.
Recently developed variants of the SARS-CoV-2 virus have been shown to be more potent
and expanded at a faster rate. Until now, there is no specific and effective treatment
for SARS-CoV-2 in terms of reliable and sustainable recovery. Precaution, prevention,
and vaccinations are the only ways to keep the pandemic situation under control. Medical
and scientific professionals are now focusing on the repurposing of previous technology
and trying to develop more fruitful methodologies to detect the presence of viruses,
treat the patients, precautionary items, and vaccine developments. Nanomedicine or
nanobased platforms can play a crucial role in these fronts. Researchers are working on
many effective approaches by nanosized particles to combat SARS-CoV-2. The role of a
nanobased platform to combat SARS-CoV-2 is extremely diverse (i.e., mark to personal
protective suit, rapid diagnostic tool to targeted treatment, and vaccine developments).
Although there are many theoretical possibilities of a nanobased platform to combat
SARS-CoV-2, until now there is an inadequate number of research targeting SARS-CoV-2 to
explore such scenarios. This unique mini-review aims to compile and elaborate on the
recent advances of nanobased approaches from prevention, diagnostics, treatment to
vaccine developments against SARS-CoV-2, and associated challenges.